The utility of pediatric age-based weight estimation formulas for emergency drug dose calculations in obese children

Mike Wells1, Lara Goldstein1

  • 1Division of Emergency Medicine Faculty of Health Sciences University of the Witwatersrand Parktown Johannesburg South Africa.

Insights

Age-based formulas are inaccurate for estimating ideal body weight and total body weight in obese children. Length-based methods like the PAWPER XL tape are more reliable for drug dosing in emergency care.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Pharmacology
  • Obesity Research

Background:

  • Accurate weight estimation is crucial for drug dosing in obese children during emergencies.
  • Previous speculation suggested age-based formulas could predict ideal body weight.
  • This study aimed to validate these age-based formulas.

Purpose of the Study:

  • To evaluate the accuracy of age-based weight estimation formulas in obese children.
  • To compare these formulas against measured ideal body weight and total body weight.
  • To determine their suitability for emergency drug dose calculations.

Main Methods:

  • A secondary analysis of pooled data from 3 South African academic emergency departments.
  • Evaluation of three age-based weight estimation formulas (Advanced Life Support, Best Guess).
  • Comparison of formula estimates against measured weights and the PAWPER XL tape using the percentage within 10% (PW10) outcome measure.

Main Results:

  • Age-based formulas showed low accuracy for ideal body weight (PW10s ranging from 29% to 48.3%) and total body weight (PW10s ranging from 3.6% to 19.0%).
  • The PAWPER XL tape demonstrated significantly higher accuracy for ideal body weight (100%) and acceptable accuracy for total body weight (49.7%).
  • All tested age-based formulas were substantially less accurate than the PAWPER XL tape.

Conclusions:

  • Age-based weight estimation formulas are unreliable for obese children in emergency settings.
  • These formulas should not be used for calculating ideal body weight or total body weight.
  • Length-based methods, such as the PAWPER XL tape, are recommended for accurate weight estimation.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
125
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
106
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
150
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
122
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
82
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
131